Cargando…
Guideline-based management of non-muscle invasive bladder cancer
INTRODUCTION: Non-muscle invasive bladder cancer (NMIBC) represents a broad spectrum of disease, the hallmarks of which include disease recurrence and progression. Clinicians have a number of surgical and therapeutic options at their disposal when treating this disease, and the underlying evidence c...
Autores principales: | Gregg, Justin R., Dahm, Philipp, Chang, Sam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626916/ https://www.ncbi.nlm.nih.gov/pubmed/26604443 http://dx.doi.org/10.4103/0970-1591.163305 |
Ejemplares similares
-
Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
por: Han, Mi Ah, et al.
Publicado: (2021) -
Are we following the guidelines on non-muscle invasive bladder cancer?
por: Reis, Leonardo Oliveira, et al.
Publicado: (2016) -
Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)
por: Power, Nicholas E., et al.
Publicado: (2016) -
Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019) -
Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations
por: Zhang, Jing, et al.
Publicado: (2019)